-
1
-
-
0008606068
-
American Psychiatric Association: practice guidelines for the treatment of patients with delirium
-
updated 2004
-
[No authors listed]. American Psychiatric Association: practice guidelines for the treatment of patients with delirium. Am J Psychiatry 1999;156(5 Suppl):1-20, updated 2004.
-
(1999)
Am J Psychiatry
, vol.156
, Issue.5
, pp. 1-20
-
-
-
3
-
-
84872269776
-
Haloperidol prophylaxis in critically ill patients with a high risk for delirium
-
van den Boogaard M, Schoonhoven L, van Achterberg T, et al. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care 2013; 17:R9.
-
(2013)
Crit Care
, vol.17
, pp. R9
-
-
van den Boogaard, M.1
Schoonhoven, L.2
van Achterberg, T.3
-
4
-
-
84891385627
-
Prophylactic antipsychotic use for postoperative delirium: a systematic review and meta-analysis
-
Hirota T, Kishi T. Prophylactic antipsychotic use for postoperative delirium: a systematic review and meta-analysis. J Clin Psychiatry 2013;74:e1136-44.
-
(2013)
J Clin Psychiatry
, vol.74
, pp. e1136-e1144
-
-
Hirota, T.1
Kishi, T.2
-
5
-
-
84871224555
-
-
(accessed 22 Jun 2013)
-
Information for Healthcare Professionals: Haloperidol. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085203.htm(accessed 22 Jun 2013).
-
Information for Healthcare Professionals: Haloperidol
-
-
-
6
-
-
77649245968
-
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation
-
Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation 2010;121: 1047-60.
-
(2010)
Circulation
, vol.121
, pp. 1047-1060
-
-
Drew, B.J.1
Ackerman, M.J.2
Funk, M.3
-
7
-
-
84872222369
-
Unsafe use of intravenous haloperidol: evaluation of recommendation-concordant care among hospitalized elderly
-
Cheung D, Wolfe B, Wald H, et al. Unsafe use of intravenous haloperidol: evaluation of recommendation-concordant care among hospitalized elderly. J Am Geriatr Soc 2013;61:160-1.
-
(2013)
J Am Geriatr Soc
, vol.61
, pp. 160-161
-
-
Cheung, D.1
Wolfe, B.2
Wald, H.3
-
8
-
-
84901849989
-
Overrides of medication-related clinical decision support alerts in outpatients
-
Nanji KC, Slight SP, Seger DL, et al. Overrides of medication-related clinical decision support alerts in outpatients. J Am Med Inform Assoc 2014;21:487-91.
-
(2014)
J Am Med Inform Assoc
, vol.21
, pp. 487-491
-
-
Nanji, K.C.1
Slight, S.P.2
Seger, D.L.3
-
9
-
-
34247329799
-
e-Iatrogenesis: the most critical unintended consequence of CPOE and other HIT
-
Weiner JP, Kfuri T, Chan K, et al. e-Iatrogenesis: the most critical unintended consequence of CPOE and other HIT. J Am Med Inform Assoc 2007;14: 387-8.
-
(2007)
J Am Med Inform Assoc
, vol.14
, pp. 387-388
-
-
Weiner, J.P.1
Kfuri, T.2
Chan, K.3
-
10
-
-
84855698737
-
Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation
-
Kesselheim A, Cresswell K, Phansalkar S, et al. Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation. Health Affairs 2011;30:2310-17.
-
(2011)
Health Affairs
, vol.30
, pp. 2310-2317
-
-
Kesselheim, A.1
Cresswell, K.2
Phansalkar, S.3
-
11
-
-
84876584728
-
Institution-wide QT alert system identifies patients with a high risk of mortality
-
Haugaa KH, Bos M, Tareell RF, et al. Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc 2013;88:315-25.
-
(2013)
Mayo Clin Proc
, vol.88
, pp. 315-325
-
-
Haugaa, K.H.1
Bos, M.2
Tareell, R.F.3
-
12
-
-
84864973164
-
A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization
-
Muzyk AJ, Rivelli SK, Jiang W, et al. A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization. Drug Saf 2012;35:725-31.
-
(2012)
Drug Saf
, vol.35
, pp. 725-731
-
-
Muzyk, A.J.1
Rivelli, S.K.2
Jiang, W.3
-
13
-
-
0032556180
-
Effect of computerized physician order entry and a team intervention on prevention of serious medication errors
-
Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311-16.
-
(1998)
JAMA
, vol.280
, pp. 1311-1316
-
-
Bates, D.W.1
Leape, L.L.2
Cullen, D.J.3
-
15
-
-
77950934586
-
The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
-
Meyer-Massetti C, Cheng CM, Sharpe BA, et al. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med 2010;5:E8-16.
-
(2010)
J Hosp Med
, vol.5
, pp. E8-E16
-
-
Meyer-Massetti, C.1
Cheng, C.M.2
Sharpe, B.A.3
-
17
-
-
84863283408
-
Towards meaningful medication-related clinical decision support: recommendations for an initial implementation
-
Phansalkar S, Wright A, Kuperman G, et al. Towards meaningful medication-related clinical decision support: recommendations for an initial implementation. Appl Clin Inf 2011;2:50-62.
-
(2011)
Appl Clin Inf
, vol.2
, pp. 50-62
-
-
Phansalkar, S.1
Wright, A.2
Kuperman, G.3
-
18
-
-
0034947780
-
Reducing the frequency of errors in medicine using information technology
-
Bates DW, Cohen M, Leape LL, et al. Reducing the frequency of errors in medicine using information technology. J Am Med Inform Assoc 2001;8:299-308.
-
(2001)
J Am Med Inform Assoc
, vol.8
, pp. 299-308
-
-
Bates, D.W.1
Cohen, M.2
Leape, L.L.3
|